Found 6 matching trials
Efficacy, Safety, and Pharmacokinetics Study of CJM112 in Hidradenitis Suppurativa Patients
PHASE2This is a randomized, double blind, multicenter study in patients with mode...
Location
Novartis Investigative Site
Study to Assess the Efficacy and Safety of CJM112 in Patients With Inadequately Controlled Severe Asthma
PHASE2An unmet medical need exists for patients with moderate and severe asthma w...
Location
Novartis Investigative Site
Single and Multiple Dose Escalation Study to Assess the Safety and Tolerability of CJM112 in Psoriasis
PHASE1A randomized, double-blind, placebo and positive controlled, single and mul...
Location
Novartis Investigative Site
A Study of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)
PHASE1The purpose of this study was to combine the PDR001 checkpoint inhibitor wi...
Location
Sidney Kimmel Comprehensive Cancer Center SC-3
Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple Myeloma
PHASE1The purpose of this study is to assess the safety, tolerability, and identi...
Location
Mayo Clinic Arizona
Study of Efficacy and Safety of CJM112 in Patients With Moderate to Severe Inflammatory Acne
PHASE2The study was designed primarily to assess preliminary efficacy and safety ...
Location
Novartis Investigative Site